Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 12/6/2007


1.		Phase II Study of Rhenium-186 HEDP in Prostate Cancer Patients with Symptomatic Skeletal Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 21								MSKCC-89129A1 NCI-V90-0033

Last Modified: 11/1/1991


2.		Phase II Study of Repeated Administrations of Rhenium-186 HEDP in Patients with Skeletal Metastases From Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 21								MSKCC-90087 NCI-V90-0149

Last Modified: 2/1/1991


3.		Phase I Study of Escalating Doses of Rhenium-186 HEDP in Patients with Skeletal Metastases from Prostate Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				over 21								MSKCC-90088 NCI-V90-0150

Last Modified: 7/1/1991


4.		Phase I Study of Escalating Activities of Rhenium-186 HEDP in Patients with Skeletal Metastases from Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				over 21								MSKCC-91004 NCI-V91-0072

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute